InvestorsHub Logo
Followers 13
Posts 2481
Boards Moderated 0
Alias Born 12/24/2014

Re: A deleted message

Monday, 06/11/2018 7:45:41 PM

Monday, June 11, 2018 7:45:41 PM

Post# of 140510
Since many folks seem to be so negative on this I’m gonna take the complete opposite opinion- My guess, we uplist right around the $7-$9 range, and see $10-$12 or more on the first trading day on Nasdaq.

We continue higher to trade north of $15 ($.50 pre RS) per share before the end of summer, as the market continues to applaud the updates from Thursday’s AGM (which lifts us into the mid .20s by next week), the new COB hire (announced within next 30 days, hopefully before the uplist date), as well as further PRs yet to come through the coming months.

Warrant money begins to come in and later this fall we do 1 dilutive raise (no warrants) to get the money needed though FDA approval ($40M needed, less with warrant money). Then, after design freeze and near submission, we line up 1 or more distribution partners who are willing to offer funds for exclusivity, and we wrap up the last of the needed financing to get us through initial commercialization ($10M needed, less with warrant money).

All IMO... ;)